SCHEMBL9609341

SCHEMBL9609341

O=C(NC(=O)c1ccccc1O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.74
CRHBP P24387 1/20 0.74
RAB9A P51151 1/20 0.74
CRHR2 Q13324 1/20 0.74
P2RX1 P51575 3/20 0.64
LMNA P02545 2/20 0.57
HTT P42858 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 2/20 0.56
POLB P06746 2/20 0.56
KDM4E B2RXH2 1/20 0.56
PTBP1 P26599 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
MEN1 O00255 1/20 0.56
P2RX4 Q99571 1/20 0.56
P2RX7 Q99572 1/20 0.56
KCNK3 O14649 1/20 0.55
TLR7 Q9NYK1 1/20 0.54
RXFP1 Q9HBX9 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5307253 0.85 NPC1 (1.00) NPC1CRHBPRAB9ACRHR2P2RX1
SCHEMBL15372570 0.79 NPC1 (0.55) NPC1CRHBPRAB9ACRHR2LMNA
SCHEMBL6991713 0.79 LMNA (0.67) RAB9AP2RX1LMNAHTTKMT2A
SCHEMBL11868617 0.78 PTGS1 (0.72) NPC1RAB9AP2RX1LMNAHTT
Salfluverine SCHEMBL2700016 0.78 P2RX1 (1.00) P2RX1MAPTP2RX4P2RX7RXFP1
SCHEMBL19032011 0.78 NPC1 (0.70) NPC1CRHBPRAB9ACRHR2LMNA
SCHEMBL9593411 0.77 P2RX1 (0.65) RAB9AP2RX1LMNAHTTKMT2A
SCHEMBL30137430 0.77 NPSR1 (0.69) RAB9AP2RX1LMNAHTTKMT2A
SCHEMBL1417591 0.77 NPSR1 (0.69) RAB9AP2RX1LMNAHTTKMT2A
SCHEMBL9609272 0.77 RAB9A (0.53) NPC1CRHBPRAB9ACRHR2P2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957140-B2 Triazine derivative, ultraviolet absorber, and resin composition FUJIFILM CORPORATION (JP) 2015-02-17 US disclosed
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION FUJIFILM CORPORATION (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136098-A1 NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION C1R, RPSA, H1-2 NPC1 4182/4885CRHBP 462/4885RAB9A 2727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.